Detection and quantification of new designer drugs in human blood: Part 2 - designer cathinones

Journal of Analytical Toxicology

Volumn 36, Issue 6, 2012, Pages 381-389

  Ammann, Dominic ^a   McLaren, Jenna M ^a   Gerostamoulos, Dimitri ^a,b   Beyer, Jochen ^a,b  

^a VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLOROBUTANE; 2 PROPANOL; 3 FLUOROMETHCATHINONE; 4 FLUOROMETHCATHINONE; 4 METHOXYMETHCATHINONE; 4 METHYLMETHCATHINONE; 4 METHYLMETHCATHINONE D3; ALPHA PYRROLIDIONOPROPIOPHENONE; AMFEPRAMONE; AMFEPRAMONE D10; BUTANE; BUTYLONE; BUTYLONE D3; CATHINONE; EPHEDRINE; ETHCATHINONE; METHCATHINONE; METHYLENEDIOXY ALPHA PYRROLIDIONOPROPIOPHENONE; METHYLENEDIOXYETHCATHINONE; METHYLENEDIOXYMETHCATHINONE; METHYLENEDIOXYMETHCATHINONE D3; METHYLEPHEDRINE; N,N DIMETHYLCATHINONE; NOREPHEDRINE; NOREPHEDRINE D3; NORPSEUDOEPHEDRINE; PHENYLEPHRINE; PSEUDOEPHEDRINE; PSEUDOEPHEDRINE D3; UNCLASSIFIED DRUG; UNINDEXED DRUG; ALKALOID; CENTRAL STIMULANT AGENT; DESIGNER DRUG; PSYCHOTROPIC AGENT; STREET DRUG;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; BLOOD; CHEMISTRY; FORENSIC TOXICOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNATIONAL COOPERATION; LIMIT OF DETECTION; METHODOLOGY; PRACTICE GUIDELINE; REPRODUCIBILITY; STANDARD; SUBSTANCE ABUSE;

ALKALOIDS; CALIBRATION; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; EPHEDRINE; FORENSIC TOXICOLOGY; GUIDELINES AS TOPIC; HUMANS; INTERNATIONAL AGENCIES; LIMIT OF DETECTION; MICROCHEMISTRY; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84866776116     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks049     Document Type: Article

References (33)

1. Kalix, P. (1991) The pharmacology of psychoactive alkaloids from ephedra and catha. Journal of Ethnopharmacology, 32, 201-208.
2. Ramawat, K.G. (2009) Herbal drugs of abuse (Beyer, Drummer, Maurer). In Herbal drugs-Ethnomedicine to modern medicine. Springer, Heidelberg.
3. Kalix, P. (1990) Pharmacological properties of the stimulant khat. Pharmacology and Therapeutics, 48, 397-416.
4. Kalix, P. (1986) The releasing effect of the isomers of the alkaloid cathinone at central and peripheral catecholamine storage sites. Neuropharmacology, 25, 499-501.
5. Kalix, P. (1984) The pharmacology of khat. General Pharmacology, 15, 179-187.
6. Kelly, J.P. (2011) Cathinone derivatives: A review of their chemistry, pharmacology and toxicology. Drug Testing and Analysis, 3, 439-453.
7. Sanchez, S.d.B. (1929) Toluyl-alpha-monomethylaminoethylcetone. Bulletin de la Societe Chimique de France, 1-54.
8. Cahill, K., Stead, L.F., Lancaster, T. (2007) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews: CD006103.
9. Lader, M. (2011) Foreword. A comprehensive review of bupropion. Clinical Drug Investigation, 31, 1-3.
10. Ioannides-Demos, L.L., Piccenna, L., McNeil, J.J. (2011) Pharmacotherapies for obesity: Past, current, and future therapies. Journal of Obesity, 2011, 179674.
11. Meltzer, P.C., Butler, D., Deschamps, J.R., Madras, B.K. (2006) 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: A promising class of monoamine uptake inhibitors. Journal of Medicinal Chemistry, 49, 1420-1432.
12. Zaitsu, K., Katagi, M., Tatsuno, M., Sato, T., Tsuchihashi, H., Suzuki, K. (2011) Recently abused beta-keto derivatives of 3,4-methylenedioxyphenylalkylamines: A review of their metabolisms and toxicological analysis. Forensic Toxicology, 29, 12.
13. Collins, M. (2011) Some new psychoactive substances: Precursor chemicals and synthesis-driven end-products. Drug Testing and Analysis, 3, 404-416.
14. Westphal, F., Junge, T., Rosner, P., Sonnichsen, F., Schuster, F. (2009) Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: A designer drug with alpha-pyrrolidinophenone structure. Forensic Science International, 190, 1-8.
15. Westphal, F., Junge, T., Rosner, P., Fritschi, G., Klein, B., Girreser, U. (2007) Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-Methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenone. Forensic Science International, 169, 32-42.
16. Vardakou, I., Pistos, C., Spiliopoulou, C. (2011) Drugs for youth via Internet and the example of mephedrone. Toxicology Letters, 201, 191-195.
17. Griffiths, P., Lopez, D., Sedefov, R., Gallegos, A., Hughes, B., Noor, A. et al. (2010) Khat use and monitoring drug use in Europe: The current situation and issues for the future. Journal of Ethnopharmacology, 132, 578-583.
18. EMCDDA. (2010) Joint report on a new psychoactive substance: 4-Methylmethcathinone (mephedrone). European Monitoring Centre for Drugs and Drug Addiction. EMCDDA, Lisbon.
19. Torrance, H., Cooper, G. (2010) The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Science International, 202, 62-63.
20. Friel, P.N., Logan, B.K., Fligner, C.L. (1993) Three fatal drug overdoses involving bupropion. Journal of Analytical Toxicology, 17, 436-438.
21. Wikstrom, M., Thelander, G., Nystrom, I., Kronstrand, R. (2010) Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). Journal of Analytical Toxicology, 34, 594-598.
22. Beyer, J., Peters, F.T., Kraemer, T., Maurer, H.H. (2007) Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. Journal of Mass Spectrometry, 42, 150-160.
23. Kriikku, P., Wilhelm, L., Schwarz, O., Rintatalo, J. (2011) New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Science International, 210, 195-200.
24. Sorensen, L.K. (2011) Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. Journal of Chromatography B, 879, 727-736.
25. Lho, D.S., Lee, J., Kim, S., Park, J., Shin, H.S. (1996) Identification of a pyrovalerone metabolite in the rat by gas chromatography-mass spectrometry and determination of pyrovalerone by gas chromatography-nitrogen-phosphorus detection. Journal of Chromatography B, 687, 253-259.
26. Sauer, C., Hoffmann, K., Schimmel, U., Peters, F.T. (2011) Acute poisoning involving the pyrrolidinophenone-type designer drug 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP). Forensic Science International, 208, 20-25.
27. Shin, H.S., Shin, Y.S., Lee, S., Park, B.B. (1996) Detection and identification of pyrovalerone and its hydroxylated metabolite in the rat. Journal of Analytical Toxicology, 20, 568-572.
28. Beyer, J., Peters, F.T., Kraemer, T., Maurer, H.H. (2007) Detection and validated quantification of toxic alkaloids in human blood plasma-Comparison of LC-APCI-MS with LC-ESI-MS/MS. Journal of Mass Spectrometry, 42, 621-633.
29. Shah, V.P., Midha, K.K., Findlay, J.W., Hill, H.M., Hulse, J.D., McGilveray, I.J. et al. (2000) Bioanalytical method validation-A revisit with a decade of progress. Pharmaceutical Research, 17, 1551-1557.
30. Peters, F.T., Maurer, H.H. (2002) Bioanalytical method validation and its implications for forensic and clinical toxicology-A review. Accreditation and Quality Assurance, 7, 441-449.
31. Peters, F.T., Drummer, O.H., Musshoff, F. (2007) Validation of new methods. Forensic Science International, 165, 216-224.
32. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
33. U.S Department of Health and Human Services. (2001) Guidance for Industry Bioanalytical Method Validation, Washington, DC.